CMS released a preliminary list of 101 generic drugs for its Medicare $2 Drug List Model, which aims to cap out-of-pocket costs at $2 per month for select medications. The initial list includes common ...

After the Centers for Medicare & Medicaid Services (CMS) revealed the list of drugs set to face the first round of price negotiations under the Inflation Reduction Act (IRA), the drugmakers ...

The negotiations with participating drug companies will occur in 2023 and 2024, and any negotiated prices will become effective beginning in 2026. President Biden released this statement: "When ...

CMS states that “[f]rom time to time, ASP public files need to be corrected or updated … based on feedback received after the files are published. If CMS receives feedback that necessitates updates to ...

The Centers for Medicare and Medicaid Services is testing three models to lower the price of drugs, including having a $2 Medicare drug list for about 150 low-cost generics. The Medicare $2 Drug List ...

(The Hill) – The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including the high-cost medications ...